Startup · $469.7k raised

ProGenis Pharmaceuticals

Developing nucleic acid therapy for aortic stenosis

Investors

Every investor coverage indicates participated in a round ProGenis Pharmaceuticals raised.

Investor	Rounds	Invested
Innovation Seed Fund	Grant	-
MTPConnect	Accelerator · Grant	-
WA Future Health Research and Innovation Fund	Grant	-

What ProGenis Pharmaceuticals bought

Companies ProGenis Pharmaceuticals acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
ProGenis Pharmaceuticals is not recorded as having acquired anything.

People

Name	Role	Sources

Something wrong? Tell us

ProGenis Pharmaceuticals

Funding history

Investors

What ProGenis Pharmaceuticals bought

People

Coverage

Cheque-in: 17 ANZ startups – plus Brooki and The Memo – raised $59.61 million this week

Western Australia backs 12 medtech startup ideas with $5 million in Seed funding

Life sciences investor MTPConnect injects $12 million into 14 drug and device startups